נוגדנים כנגד– 12–il/ 23–il

• 收藏
• 分享

专利权人:

TEVA PHARMACEUTICALS AUSTRALIA PTY LTD

发明人:

申请号：

IL21090311

公开号：

IL210903A

申请日:

2011.01.27

申请国别(地区):

IL

年份:

2016

代理人:

摘要：

The present invention provides an antibody comprising an antigen binding domain which binds to human IL-12 and human IL-23. The antibody binds human IL-12p40 existing as a monomer (human IL-12p40) and as a homodimer (human IL-12p80) and the antibody inhibits the binding of human IL-12 to human IL-12R beta2 and human IL-23 to human IL-23R but does not inhibit the binding of human IL-12 or human IL-23 or human IL-12p40 or human IL-12p80 to human IL-12Rbeta1.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/